Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Marta Crispens, MD, Vanderbilt-Ingram Cancer Center Identifier:
First received: May 9, 2009
Last updated: April 17, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)